BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
QuintilesIMS
Boehringer Ingelheim
Deloitte
Teva
Novartis
Argus Health
Johnson and Johnson
McKesson
US Department of Justice

Generated: January 22, 2018

DrugPatentWatch Database Preview

DEXTROSE 60% Drug Profile

« Back to Dashboard

When do Dextrose 60% patents expire, and when can generic versions of Dextrose 60% launch?

Dextrose 60% is a drug marketed by B Braun, Baxter Hlthcare, and Hospira. and is included in four NDAs.

The generic ingredient in DEXTROSE 60% is dextrose. There are eight drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the dextrose profile page.

US Patents and Regulatory Information for DEXTROSE 60%

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
B Braun DEXTROSE 60% dextrose INJECTABLE;INJECTION 017995-002 Sep 22, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Baxter Hlthcare DEXTROSE 60% IN PLASTIC CONTAINER dextrose INJECTABLE;INJECTION 020047-002 Jul 2, 1991 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
B Braun DEXTROSE 60% IN PLASTIC CONTAINER dextrose INJECTABLE;INJECTION 017995-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Baxter Hlthcare DEXTROSE 60% IN PLASTIC CONTAINER dextrose INJECTABLE;INJECTION 017521-005 Mar 26, 1982 AP RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira DEXTROSE 60% IN PLASTIC CONTAINER dextrose INJECTABLE;INJECTION 019346-001 Jan 25, 1985 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Accenture
Cantor Fitzgerald
US Department of Justice
Baxter
Johnson and Johnson
Deloitte
Healthtrust
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot